Skp2 regulates G2/M progression in a p53-dependent manner.

Molecular Biology of the Cell
Rong Hu, A E Aplin

Abstract

Targeted proteasomal degradation mediated by E3 ubiquitin ligases controls cell cycle progression, and alterations in their activities likely contribute to malignant cell proliferation. S phase kinase-associated protein 2 (Skp2) is the F-box component of an E3 ubiquitin ligase complex that targets p27(Kip1) and cyclin E1 to the proteasome. In human melanoma, Skp2 is highly expressed, regulated by mutant B-RAF, and required for cell growth. We show that Skp2 depletion in melanoma cells resulted in a tetraploid cell cycle arrest. Surprisingly, co-knockdown of p27(Kip1) or cyclin E1 failed to prevent the tetraploid arrest induced by Skp2 knockdown. Enhanced Aurora A phosphorylation and repression of G2/M regulators cyclin B1, cyclin-dependent kinase 1, and cyclin A indicated a G2/early M phase arrest in Skp2-depleted cells. Furthermore, expression of nuclear localized cyclin B1 prevented tetraploid accumulation after Skp2 knockdown. The p53 status is most frequently wild type in melanoma, and the tetraploid arrest and down-regulation of G2/M regulatory genes were strongly dependent on wild-type p53 expression. In mutant p53 melanoma lines, Skp2 depletion did not induce cell cycle arrest despite up-regulation of p27(Kip1). These da...Continue Reading

References

Feb 1, 1991·Pigment Cell Research·M VolkenandtA P Albino
Jun 19, 1993·International Journal of Cancer. Journal International Du Cancer·J WeissK C Arden
Apr 8, 1998·Current Opinion in Genetics & Development·W Krek
Nov 13, 1999·Nature Cell Biology·A C CarranoM Pagano
Nov 17, 1999·Molecular Biology of the Cell·W R TaylorG R Stark
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·E LatresM Pagano
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·M GstaigerW Krek
May 12, 2001·Cell·B A Edgar, T L Orr-Weaver
May 22, 2001·Molecular Biology of the Cell·P R AndreassenR L Margolis
Oct 19, 2001·EMBO Reports·S SciortinoG Piaggio
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 26, 2002·Nature Genetics·Pamela M PollockPaul S Meltzer
May 6, 2003·The Journal of Biological Chemistry·Gil BornsteinAvram Hershko
May 29, 2003·Molecular Cell·So Young KimWilliam P Tansey
May 29, 2003·The Journal of Biological Chemistry·Giuseppina CarettiRoberto Mantovani
Jun 26, 2003·Cancer Science·Sana YokoiJohji Inazawa
Aug 12, 2003·The Journal of Biological Chemistry·Yasutoshi TatsumiChikashi Obuse
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Takumi KamuraKeiichi I Nakayama
Aug 28, 2003·Cell·Yan GengPiotr Sicinski
Mar 17, 2004·Oncogene·Daniele Guardavaccaro, Michele Pagano
May 8, 2004·Developmental Cell·Keiko NakayamaKeiichi I Nakayama
Oct 20, 2004·Journal of Cutaneous Pathology·Qing LiJ Andrew Carlson
Nov 3, 2004·Genes & Development·Uta KossatzNisar P Malek
Jan 5, 2005·Nature Reviews. Cancer·Tomotoshi MarumotoHideyuki Saya
Apr 15, 2005·Nature·Vassilis G GorgoulisThanos D Halazonetis
Apr 16, 2005·Molecular and Cellular Biology·Carol ImbrianoRoberto Mantovani
Jul 30, 2005·International Journal of Cancer. Journal International Du Cancer·Hidetoshi SumimotoYutaka Kawakami
Aug 5, 2005·Nature·Chrysiis MichaloglouDaniel S Peeper
Mar 1, 2006·Journal of Dermatological Science·Yoshiyuki KatagiriShigeo Kondo
Mar 21, 2006·Oncogene·K Boisvert-Adamo, A E Aplin
Apr 25, 2006·Nature Reviews. Cancer·Keiichi I Nakayama, Keiko Nakayama
Jul 4, 2006·Nature Reviews. Drug Discovery·Grzegorz NalepaJ Wade Harper
Sep 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Inke TimmerbeulNisar P Malek
Nov 8, 2006·Molecular Cancer Therapeutics·Ogechi N IkediobiRichard Wooster
Dec 1, 2006·Nature·Raffaella Di MiccoFabrizio d'Adda di Fagagna

❮ Previous
Next ❯

Citations

Apr 2, 2010·Journal of Assisted Reproduction and Genetics·Ann A KiesslingDimitris Loutradis
Nov 1, 1987·Trends in Ecology & Evolution·P M Sharp, W H Li
Jan 14, 2010·Pigment Cell & Melanoma Research·Rong Hu, Andrew E Aplin
Oct 5, 2010·Pigment Cell & Melanoma Research·Amy E RoseIman Osman
Nov 15, 2012·Genes & Cancer·Ian M Love, Steven R Grossman
Feb 26, 2010·Cell Division·C Elizabeth Caldon, Elizabeth A Musgrove
Aug 31, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Chuck C-K Chao
Mar 31, 2015·Nature Communications·Dazhi XuHui-Kuan Lin
Jun 8, 2013·Biochimica Et Biophysica Acta·Andreas K Hock, Karen H Vousden
May 16, 2017·Oncogenesis·S T GuoC C Jiang
Aug 6, 2017·Cell and Tissue Research·Marcela S ProcópioLuiz R de França
Nov 22, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lei LyuAllen Taylor
Aug 25, 2020·American Journal of Physiology. Renal Physiology·Chen YeChun Zhang
Feb 10, 2018·Oncotarget·Anna A BrożynaJ Andrew Carlson
Mar 25, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Danielle D JandialXiaolin Zi
Sep 9, 2017·Scientific Reports·Jacinta L SimmonsGlen M Boyle
Oct 22, 2019·Frontiers in Physiology·Shahd FouadVincenzo D'Angiolella
Sep 17, 2021·Biochemical Pharmacology·Jeong-Su ParkYoon-Seok Roh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.